PT - JOURNAL ARTICLE AU - Robertson, Leon S. TI - Predicting Growth of COVID-19 Confirmed Cases in Each U.S. County with a Population of 50,000 or More, Revised July 8, 2020 AID - 10.1101/2020.05.29.20117044 DP - 2020 Jan 01 TA - medRxiv PG - 2020.05.29.20117044 4099 - http://medrxiv.org/content/early/2020/07/11/2020.05.29.20117044.short 4100 - http://medrxiv.org/content/early/2020/07/11/2020.05.29.20117044.full AB - A simple model of local spread of COVID-19 is needed to assist local governments and health care providers prepare for surges of clinical cases in their communities. National and state based models are inadequate because the virus is introduced and spreads at different rates in local areas. In the U.S. as of July 3, 2020, 73 percent of cases and 84 percent of deaths occurred in the 200 counties with the most cases and deaths. Each county has its own function of cases in time that can be used to predict increases in reported cases two weeks in advance for each of 988 counties in the U.S. with populations of 50,000 or more inhabitants. A logarithmic model based on growth in cases during the past 30 days is substantially predictive of increase in cases during the subsequent 14 days. Predicted increase in cases for the 988 U.S. counties will be published online daily.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe work was not funded.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:None required because this is a study of publically available statistics.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesReferences to the public datasets are in the paper as well as a link to a file of parameters for users of the method. https:www.nanlee.net